| pubmed-article:10037026 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0023418 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0015576 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C1334292 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0524637 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0424295 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0034819 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0037083 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0033681 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0337076 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C0443199 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C1710236 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C1513403 | lld:lifeskim |
| pubmed-article:10037026 | lifeskim:mentions | umls-concept:C2698977 | lld:lifeskim |
| pubmed-article:10037026 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:10037026 | pubmed:dateCreated | 1999-5-26 | lld:pubmed |
| pubmed-article:10037026 | pubmed:abstractText | Substrate recognition by Janus family protein tyrosine kinases was examined utilizing recombinant baculovirus produced components of the interleukin 2 receptor (IL2R) system i.e. Jak1, Transducers and Activators of Transcription (STAT). Wild type Jak3 was able to tyrosine phosphorylate a kinase-dead Jak1 (Jak1E908). In contrast wild type Jak1 was unable to tyrosine phosphorylate kinase dead Jak3 (Jak3E851). This unilateral transphosphorylation between Jak3 and Jak1 prompts the hypothesis that in the IL2R system the activation of Jak3 precedes Jak1 activation. Both the IL2Rbeta and IL2Rgammac subunits underwent tyrosine phosphorylation when co-expressed with wild-type Jak3. By comparison only IL2Rbeta was recognized and tyrosine phosphorylated by wild-type Jak1. These results are consistent with the notion that Jakl is pre-associated with IL2Rbeta and Jak3 is pre-associated with IL2Rgammac. STAT1, STAT3, and STAT5 underwent tyrosine phosphorylation when co-expressed with Jakl and therefore are substrates for the respective Jak kinases. In contrast, Jak3 co-expression resulted in tyrosine phosphorylation of STAT3 and STAT5 but not STAT1. Notably a polypeptide representing the kinase domain of Jak3 (Jak3-JH1) gained the ability to tyrosine phosphorylate STAT1, suggesting that the changes in substrate recognition may be influenced by domains outside the kinase domain. These findings provide evidence that Jak1 and Jak3 differentially recognize specific substrates, thereby having the ability to contribute specific signals, and the substrate specificity may be influenced by multiple domains of these tyrosine kinases. | lld:pubmed |
| pubmed-article:10037026 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10037026 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10037026 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10037026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10037026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10037026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10037026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10037026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10037026 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10037026 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:10037026 | pubmed:issn | 1042-8194 | lld:pubmed |
| pubmed-article:10037026 | pubmed:author | pubmed-author:WilliamsM DMD | lld:pubmed |
| pubmed-article:10037026 | pubmed:author | pubmed-author:UckunF MFM | lld:pubmed |
| pubmed-article:10037026 | pubmed:author | pubmed-author:WitthuhnB ABA | lld:pubmed |
| pubmed-article:10037026 | pubmed:author | pubmed-author:KerawallaHH | lld:pubmed |
| pubmed-article:10037026 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10037026 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:10037026 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10037026 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10037026 | pubmed:pagination | 289-97 | lld:pubmed |
| pubmed-article:10037026 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:meshHeading | pubmed-meshheading:10037026... | lld:pubmed |
| pubmed-article:10037026 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10037026 | pubmed:articleTitle | Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery. | lld:pubmed |
| pubmed-article:10037026 | pubmed:affiliation | Department of Biochemistry, Wayne Hughes Institute, Roseville, MN 55113, USA. | lld:pubmed |
| pubmed-article:10037026 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:3718 | entrezgene:pubmed | pubmed-article:10037026 | lld:entrezgene |
| entrez-gene:6774 | entrezgene:pubmed | pubmed-article:10037026 | lld:entrezgene |
| entrez-gene:6776 | entrezgene:pubmed | pubmed-article:10037026 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:10037026 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:10037026 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10037026 | lld:pubmed |
